Esperion Theraptc (ESPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,375 | -26,088 | -11,742 | -10,817 | N/A |
| Depreciation Amortization | 393 | 596 | 271 | 179 | N/A |
| Accounts payable and accrued liabilities | -299 | 1,756 | -215 | 619 | N/A |
| Other Working Capital | 251 | 3,226 | -839 | 802 | N/A |
| Other Operating Activity | 4,009 | 2,396 | 1,717 | 149 | 0 |
| Operating Cash Flow | $-32,021 | $-18,114 | $-10,808 | $-9,069 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -861 | 170 | -2 | 9 | N/A |
| Purchase Of Investment | -48,088 | -24,677 | N/A | N/A | N/A |
| Sale Of Investment | 12,351 | 3,505 | N/A | 500 | N/A |
| Investing Cash Flow | $-36,598 | $-21,002 | $-2 | $509 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,838 | N/A | 15,412 | N/A | N/A |
| Common Stock Issued | 92,282 | 72,317 | 339 | 16 | N/A |
| Other Financing Activity | 0 | 16,824 | 0 | 6,700 | 0 |
| Financing Cash Flow | $97,120 | $89,141 | $15,751 | $6,716 | $N/A |
| Beginning Cash Position | 56,537 | 6,512 | 1,571 | 3,415 | N/A |
| End Cash Position | 85,038 | 56,537 | 6,512 | 1,571 | N/A |
| Net Cash Flow | $28,501 | $50,025 | $4,941 | $-1,844 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,021 | -18,114 | -10,808 | -9,069 | N/A |
| Capital Expenditure | -873 | -31 | -7 | -34 | N/A |
| Free Cash Flow | -32,894 | -18,145 | -10,815 | -9,102 | 0 |